Epicardial cardiac rhythm devices for dialysis patients: Minimizing the risk of infection and preserving central veins

Arif Asif, Roger Carrillo, Juan Domingo Garisto, Gustavo Lopera, Marco Ladino, Urwa Barakat, Nadia Eid, Loay Salman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Transvenous leads of cardiac rhythm devices (CRDs) are known to cause central stenosis and are vulnerable to contamination during hemodialysis access-related bacteremia. In this retrospective study, nine consecutive chronic hemodialysis patients with transvenous CRD infection due to dialysis access-related bacteremia and recurrent central stenosis are presented. Four patients with tunneled hemodialysis catheters (TDCs) and three with arteriovenous grafts experienced access-related bacteremia that spread to the transvenous CRD. Two patients required repeated angioplasty procedures (less than 3months apart) for central venous stenosis. Transvenous CRD was removed and replaced with an epicardial system in all. One patient with TDC switched to peritoneal dialysis and did not experience infection of the epicardial system despite two episodes of peritonitis. The remaining TDC (n=3) and graft patients (n=3) received a new TDC after the resolution of bacteremia. While all six experienced on average 1.5 episodes of catheter-related bacteremia (average follow-up = 14.5months), none developed infection of the epicardial system. The patients with central stenosis have required only one angioplasty each for the past 8 and 6months. To the best of our knowledge this is the first study to suggest that an epicardial approach might be a preferred method over transvenous leads for chronic hemodialysis patients.

Original languageEnglish
Pages (from-to)88-94
Number of pages7
JournalSeminars in Dialysis
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Renal Dialysis
Dialysis
Veins
Bacteremia
Equipment and Supplies
Catheters
Infection
Pathologic Constriction
Angioplasty
Transplants
Peritoneal Dialysis
Peritonitis
Retrospective Studies

ASJC Scopus subject areas

  • Nephrology

Cite this

Epicardial cardiac rhythm devices for dialysis patients : Minimizing the risk of infection and preserving central veins. / Asif, Arif; Carrillo, Roger; Garisto, Juan Domingo; Lopera, Gustavo; Ladino, Marco; Barakat, Urwa; Eid, Nadia; Salman, Loay.

In: Seminars in Dialysis, Vol. 25, No. 1, 01.01.2012, p. 88-94.

Research output: Contribution to journalArticle

Asif, A, Carrillo, R, Garisto, JD, Lopera, G, Ladino, M, Barakat, U, Eid, N & Salman, L 2012, 'Epicardial cardiac rhythm devices for dialysis patients: Minimizing the risk of infection and preserving central veins', Seminars in Dialysis, vol. 25, no. 1, pp. 88-94. https://doi.org/10.1111/j.1525-139X.2010.00757.x
Asif, Arif ; Carrillo, Roger ; Garisto, Juan Domingo ; Lopera, Gustavo ; Ladino, Marco ; Barakat, Urwa ; Eid, Nadia ; Salman, Loay. / Epicardial cardiac rhythm devices for dialysis patients : Minimizing the risk of infection and preserving central veins. In: Seminars in Dialysis. 2012 ; Vol. 25, No. 1. pp. 88-94.
@article{e03e9067498f4ae29a776098f9727197,
title = "Epicardial cardiac rhythm devices for dialysis patients: Minimizing the risk of infection and preserving central veins",
abstract = "Transvenous leads of cardiac rhythm devices (CRDs) are known to cause central stenosis and are vulnerable to contamination during hemodialysis access-related bacteremia. In this retrospective study, nine consecutive chronic hemodialysis patients with transvenous CRD infection due to dialysis access-related bacteremia and recurrent central stenosis are presented. Four patients with tunneled hemodialysis catheters (TDCs) and three with arteriovenous grafts experienced access-related bacteremia that spread to the transvenous CRD. Two patients required repeated angioplasty procedures (less than 3months apart) for central venous stenosis. Transvenous CRD was removed and replaced with an epicardial system in all. One patient with TDC switched to peritoneal dialysis and did not experience infection of the epicardial system despite two episodes of peritonitis. The remaining TDC (n=3) and graft patients (n=3) received a new TDC after the resolution of bacteremia. While all six experienced on average 1.5 episodes of catheter-related bacteremia (average follow-up = 14.5months), none developed infection of the epicardial system. The patients with central stenosis have required only one angioplasty each for the past 8 and 6months. To the best of our knowledge this is the first study to suggest that an epicardial approach might be a preferred method over transvenous leads for chronic hemodialysis patients.",
author = "Arif Asif and Roger Carrillo and Garisto, {Juan Domingo} and Gustavo Lopera and Marco Ladino and Urwa Barakat and Nadia Eid and Loay Salman",
year = "2012",
month = "1",
day = "1",
doi = "10.1111/j.1525-139X.2010.00757.x",
language = "English",
volume = "25",
pages = "88--94",
journal = "Seminars in Dialysis",
issn = "0894-0959",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Epicardial cardiac rhythm devices for dialysis patients

T2 - Minimizing the risk of infection and preserving central veins

AU - Asif, Arif

AU - Carrillo, Roger

AU - Garisto, Juan Domingo

AU - Lopera, Gustavo

AU - Ladino, Marco

AU - Barakat, Urwa

AU - Eid, Nadia

AU - Salman, Loay

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Transvenous leads of cardiac rhythm devices (CRDs) are known to cause central stenosis and are vulnerable to contamination during hemodialysis access-related bacteremia. In this retrospective study, nine consecutive chronic hemodialysis patients with transvenous CRD infection due to dialysis access-related bacteremia and recurrent central stenosis are presented. Four patients with tunneled hemodialysis catheters (TDCs) and three with arteriovenous grafts experienced access-related bacteremia that spread to the transvenous CRD. Two patients required repeated angioplasty procedures (less than 3months apart) for central venous stenosis. Transvenous CRD was removed and replaced with an epicardial system in all. One patient with TDC switched to peritoneal dialysis and did not experience infection of the epicardial system despite two episodes of peritonitis. The remaining TDC (n=3) and graft patients (n=3) received a new TDC after the resolution of bacteremia. While all six experienced on average 1.5 episodes of catheter-related bacteremia (average follow-up = 14.5months), none developed infection of the epicardial system. The patients with central stenosis have required only one angioplasty each for the past 8 and 6months. To the best of our knowledge this is the first study to suggest that an epicardial approach might be a preferred method over transvenous leads for chronic hemodialysis patients.

AB - Transvenous leads of cardiac rhythm devices (CRDs) are known to cause central stenosis and are vulnerable to contamination during hemodialysis access-related bacteremia. In this retrospective study, nine consecutive chronic hemodialysis patients with transvenous CRD infection due to dialysis access-related bacteremia and recurrent central stenosis are presented. Four patients with tunneled hemodialysis catheters (TDCs) and three with arteriovenous grafts experienced access-related bacteremia that spread to the transvenous CRD. Two patients required repeated angioplasty procedures (less than 3months apart) for central venous stenosis. Transvenous CRD was removed and replaced with an epicardial system in all. One patient with TDC switched to peritoneal dialysis and did not experience infection of the epicardial system despite two episodes of peritonitis. The remaining TDC (n=3) and graft patients (n=3) received a new TDC after the resolution of bacteremia. While all six experienced on average 1.5 episodes of catheter-related bacteremia (average follow-up = 14.5months), none developed infection of the epicardial system. The patients with central stenosis have required only one angioplasty each for the past 8 and 6months. To the best of our knowledge this is the first study to suggest that an epicardial approach might be a preferred method over transvenous leads for chronic hemodialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=84856301877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856301877&partnerID=8YFLogxK

U2 - 10.1111/j.1525-139X.2010.00757.x

DO - 10.1111/j.1525-139X.2010.00757.x

M3 - Article

C2 - 20807391

AN - SCOPUS:84856301877

VL - 25

SP - 88

EP - 94

JO - Seminars in Dialysis

JF - Seminars in Dialysis

SN - 0894-0959

IS - 1

ER -